SuperworthInspire Medical Systems profit margin INSP
Gross, operating and net profit as a share of revenue over the last twelve months, from 2017.
- Net margin, 12 months
- 15.0%
- Operating margin, 12 months
- 6.0%
- Net margin on a year earlier
- +8.9 pts
- Peer median
- 4.3%
Over the twelve months to Jun 30, 2026, Inspire Medical Systems kept 15.0% of its revenue as net profit, with an operating margin of 6.0% and a gross margin of 86.1%.
Five years earlier its net margin was −26.9%.
The median for 10 medical instruments and supplies stocks of a similar size is 4.3%.
Profit margin over time
Fiscal year by fiscal year
| Fiscal year | Net margin | Operating margin | Gross margin |
|---|---|---|---|
| FY2025 | 15.9% | 5.6% | 85.4% |
| FY2024 | 6.7% | 4.5% | 84.7% |
| FY2023 | −3.4% | −6.4% | 84.5% |
| FY2022 | −11.0% | −11.7% | 83.8% |
| FY2021 | −18.0% | −17.1% | 85.7% |
| FY2020 | −49.6% | −48.7% | 84.7% |
| FY2019 | −40.5% | −42.5% | 83.4% |
| FY2018 | −43.1% | −40.3% | 80.1% |
| FY2017 | −61.3% | −56.0% | 78.9% |
Quarter by quarter
| Quarter | Ended | Net margin, 12 months | Change on a year | Operating margin |
|---|---|---|---|---|
| Q2 FY26 | 15.0% | +8.9 pts | 6.0% | |
| Q1 FY26 | 14.3% | +6.4 pts | 5.6% | |
| Q4 FY25 | 15.9% | +9.3 pts | 5.6% | |
| Q3 FY25 | 5.0% | +0.7 pts | 4.2% | |
| Q2 FY25 | 6.2% | +5.3 pts | 4.8% | |
| Q1 FY25 | 7.9% | +10.3 pts | 5.9% | |
| Q4 FY24 | 6.7% | +10.1 pts | 4.5% | |
| Q3 FY24 | 4.4% | +10.1 pts | 1.8% | |
| Q2 FY24 | 0.9% | +8.7 pts | −2.0% | |
| Q1 FY24 | −2.4% | +7.0 pts | −5.4% | |
| Q4 FY23 | −3.4% | +7.6 pts | −6.4% | |
| Q3 FY23 | −5.7% | +8.7 pts | −8.8% |
Against its peers
Companies in Medical - Instruments & Supplies nearest Inspire Medical Systems' size, closest first, today.
| Company | Profit margin |
|---|---|
| INSPInspire Medical Systems | 15.0% |
| LMATLemaitre Vascular | 25.0% |
| UFPTUFP Technologies | 11.4% |
| EYENational Vision | 2.5% |
| ATRCAtriCure | 1.9% |
| WRBYWarby Parker | 0.8% |
| CDRECadre | 5.3% |
| BVSBioventus | 9.4% |
| STAAStaar Surgical | 1.1% |
| NVSTEnvista | 3.3% |
| IRMDIradimed | 26.7% |
| Peer median | 4.3% |
Where Inspire Medical Systems ranks
What the profit margin tells you
Profit as a share of revenue at three levels: gross (after making the product), operating (after running the business) and net (after everything, including tax and interest).
Compare within an industry. 10% is superb for a retailer and poor for a software company.
More on Inspire Medical Systems
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.